免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

HDH治療計劃系統

K 號:K212173 · 2022-01-25

決定日期2022-01-25
產品代碼PNN
諮詢委員會DE
決定相當於

器材摘要

HDH Treatment Planning System is the device name listed in this FDA 510(k) record. The listed applicant is Cdb Corporation. It received FDA 510(k) clearance on 2022-01-25 under 510(k) number K212173. The device is classified under product code PNN. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the HDH Treatment Planning System?

HDH Treatment Planning System is a medical device that received FDA 510(k) clearance on 2022-01-25. The listed applicant is Cdb Corporation. The 510(k) number is K212173.

When did HDH Treatment Planning System receive FDA 510(k) clearance?

HDH Treatment Planning System received FDA 510(k) clearance on 2022-01-25, under 510(k) number K212173.

Who is the listed applicant for HDH Treatment Planning System?

The FDA 510(k) record lists Cdb Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HDH Treatment Planning System?

The FDA product code for HDH Treatment Planning System is PNN.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Cdb Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:PNN)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑